This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
LOS ANGELES, Sept. 18, 2012 (GLOBE NEWSWIRE) -- RadNet, Inc. (Nasdaq:RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 237 owned and operated outpatient imaging centers, today announced that it has begun a process to refinance its existing term loan and revolving credit facility under which, as of June 30, 2012, it had approximately $338.1 million of total debt outstanding, consisting of $278.6 million of senior secured term debt and $59.5 million outstanding under its senior secured revolving credit facility.
Under the contemplated refinancing transaction, the term loan portion of this existing debt and a portion of the existing balance outstanding under the revolving credit facility would be prepaid from up to $330 million of new secured term loans. Additionally, as part of the new senior secured credit facilities, the Company is targeting a new secured revolving credit facility of between $100.0 and$125.0 million.
In connection with the marketing of the proposed new senior secured term loan and revolving credit facility, RadNet releases the following reconciliation of trailing 12 month Adjusted EBITDA
(1) as of June 30, 2012 (as previously reported) to trailing 12 month Pro Forma Adjusted EBITDA
(1), which incorporates certain adjustments to previously reported Adjusted EBITDA
(1) related to events that have taken place within the last twelve months.
($ in Thousands)
Adjusted EBITDA (1) As Reported for the Six Month Period Ended June 30 , 2012 (a)
Plus Adjusted EBITDA (1) As Reported for the 12 Month Period Ended December 31, 2011 (b)
Less Adjusted EBITDA (1) As Reported for the Six Month Period Ended June 30, 2011 (a)
Trailing 12 Month Adjusted EBITDA (1) As Reported
Plus Pro Forma Addback for Acquisitions Completed in the Last 12 Months
Plus Pro Forma Addback for the Buyout of Operating Leases Completed in the Last 12 Months
Trailing 12 Month Pro Forma Adjusted EBITDA
(1) Neither Adjusted EBITDA or Pro Forma Adjusted EBITDA are reported in accordance with generally applicable accounting principles in the United States ("
GAAP"), and are considered as "non-GAAP financial measures" pursuant to Regulation G promulgated by the Securities and Exchange Commission. The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, each from continuing operations and adjusted for losses or gains on the sale of equipment, other income or loss, debt extinguishments and non-cash equity compensation. Adjusted EBITDA includes equity earnings in unconsolidated operations and subtracts allocations of earnings to non-controlling interests in subsidiaries, and is adjusted for non-cash or extraordinary and one-time events that have taken place during the period.
Adjusted EBITDA and Pro Forma Adjusted EBITDA are reconciled to their nearest comparable GAAP financial measure, net income to RadNet, Inc. common shareholders. Adjusted EBITDA and Pro Forma Adjusted EBITDA are used as analytical indicators by RadNet management and the healthcare industry to assess business performance, and are measures of leverage capacity and ability to service debt. Neither Adjusted EBITDA or Pro Forma Adjusted EBITDA should be considered a measure of financial performance under GAAP, and the items excluded from Adjusted EBITDA or Pro Forma Adjusted EBITDA should not be considered in isolation or as alternatives to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the consolidated financial statements as an indicator of financial performance or liquidity. As Adjusted EBITDA and Pro Forma Adjusted EBITDA are not measurements determined in accordance with GAAP and are therefore susceptible to varying methods of calculation, these metrics, as presented, may not be comparable to other similarly titled measures of other companies.